Author: Devogelaer Jean-Pierre
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.5, Iss.4, 2004-04, pp. : 941-949
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
LIFT substudy assesses endometrial effects of tibolone
Reactions Weekly, Vol. 1, Iss. 1225, 2008-01 ,pp. :
Tibolone: favourable cardiovascular effects in postmenopausal women
Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. :
Tibolone has beneficial effects on the lipoprotein profile of postmenopausal women
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :
Tibolone: Endometrial cancer?: case report
Reactions Weekly, Vol. 1, Iss. 1078, 2005-01 ,pp. :
Adalimumab: a review of side effects
Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. :